CoChat

Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis

Open access
Trieu, Kathy, Bhat, Saiuj, Dai, Zhaoli, Leander, Karin, Gigante, Bruna, Qian, Frank, Korat, Andres V. Ardisson, Sun, Qi, Pan, Xiong-Fei, Laguzzi, Federica, Cederholm, Tommy, de Faire, Ulf, Hellénius, Mai-Lis, Wu, Jason H. Y., Risérus, Ulf, Marklund, Matti · 2021 · PLOS Medicine
Cited by 94

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dairy fat biomarkers (circulating or adipose tissue levels of 15:0, heptadecanoic acid [17:0], and trans -palmitoleic acid [ t 16:1n-7]) with CVD outcomes or all-cause mortality. Methods and findings: We measured 15:0 in serum cholesterol esters at baseline in 4,150 Swedish adults (51% female, median age 60.5 years). During a median follow-up of 16.6 years, 578 incident CVD events and 676 deaths were identified using Swedish registers. In multivariable-adjusted models, higher 15:0 was associated with lower incident CVD risk in a linear dose–response manner (hazard ratio 0.75 per interquintile range; 95% confidence interval 0.61, 0.93, P = 0.009) and nonlinearly with all-cause mortality (P for nonlinearity = 0.03), with a nadir of mortality risk around median 15:0. In meta-analyses including our Swedish cohort and 17 cohort, case–cohort, or nested case–control studies, higher 15:0 and 17:0 but not t 16:1n-7 were inversely associated with total CVD, with the relative risk of highest versus lowest tertile being 0.88 (0.78, 0.99), 0.86 (0.79, 0.93), and 1.01 (0.91, 1.12), respectively. Dairy fat biomarkers were not associated with all-cause mortality in meta-analyses, although there were ≤3 studies for each biomarker. Study limitations include the inability of the biomarkers to distinguish different types of dairy foods and that most studies in the meta-analyses (including our novel cohort study) only assessed biomarkers at baseline, which may increase the risk of misclassification of exposure levels. Conclusions: In a meta-analysis of 18 observational studies including our new cohort study, higher levels of 15:0 and 17:0 were associated with lower CVD risk. Our findings support the need for clinical and experimental studies to elucidate the causality of these relationships and relevant biological mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003763

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 51

  1. JHY Wu, 2019, Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes, Nat Rev Cardiol, 16, 581, 10.1038/s41569-019-0206-1 · DOI · Paper page
  2. D Mozaffarian, 2018, Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways, Circ Res, 122, 369, 10.1161/CIRCRESAHA.117.309008 · DOI · Paper page
  3. F Rosqvist, 2015, Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study, Am J Clin Nutr, 102, 20, 10.3945/ajcn.115.107045 · DOI
  4. PJ Huth, 2012, Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence, Adv Nutr, 3, 266, 10.3945/an.112.002030 · DOI · Paper page
  5. J Guo, 2017, Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies, Eur J Epidemiol, 32, 269, 10.1007/s10654-017-0243-1 · DOI · Paper page
  6. R Lordan, 2018, Dairy Fats and Cardiovascular Disease: Do We Really Need to Be Concerned?, Foods, 7, 29, 10.3390/foods7030029 · DOI · Paper page
  7. A Astrup, 2020, Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations, J Am Coll Cardiol, 76, 844, 10.1016/j.jacc.2020.05.077 · DOI · Paper page
  8. LS Freedman, 2011, Dealing With Dietary Measurement Error in Nutritional Cohort Studies, J Natl Cancer Inst, 103, 1086, 10.1093/jnci/djr189 · DOI · Paper page
  9. U Risérus, 2017, Milk fat biomarkers and cardiometabolic disease, Curr Opin Lipidol, 28, 46, 10.1097/MOL.0000000000000381 · DOI
  10. MC de Oliveira Otto, 2018, Genome-wide association meta-analysis of circulating odd-numbered chain saturated fatty acids: Results from the CHARGE Consortium, PLoS ONE, 13, e0196951, 10.1371/journal.pone.0196951 · DOI
  11. A Wolk, 2001, Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men, J Nutr, 131, 828, 10.1093/jn/131.3.828 · DOI · Paper page
  12. MC de Oliveira Otto, 2018, Serial measures of circulating biomarkers of dairy fat and total and cause-specific mortality in older adults: the Cardiovascular Health Study, Am J Clin Nutr, 108, 476, 10.1093/ajcn/nqy117 · DOI
  13. M Marklund, 2015, Polyunsaturated Fat Intake Estimated by Circulating Biomarkers and Risk of Cardiovascular Disease and All-Cause Mortality in a Population-Based Cohort of 60-Year-Old Men and Women, Circulation, 132, 586, 10.1161/CIRCULATIONAHA.115.015607 · DOI
  14. M Boberg, 1985, Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway, Clin Sci, 68, 581, 10.1042/cs0680581 · DOI · Paper page
  15. F Laguzzi, 2016, Cross-sectional relationships between dietary fat intake and serum cholesterol fatty acids in a Swedish cohort of 60-year-old men and women, J Hum Nutr Diet, 29, 325, 10.1111/jhn.12336 · DOI
  16. N Orsini, 2012, Evaluating Percentiles of Survival, Epidemiology, 23, 770, 10.1097/EDE.0b013e3182625eff · DOI · Paper page
  17. J Liang, 2018, Biomarkers of dairy fat intake and risk of cardiovascular disease: A systematic review and meta analysis of prospective studies, Crit Rev Food Sci Nutr, 58, 1122, 10.1080/10408398.2016.1242114 · DOI
  18. E Warensjö, 2004, Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study, Br J Nutr, 91, 635, 10.1079/BJN20041080 · DOI · Paper page
  19. E Warensjö, 2009, Stroke and plasma markers of milk fat intake—a prospective nested case-control study, Nutr J, 8, 21, 10.1186/1475-2891-8-21 · DOI
  20. E Warensjö, 2010, Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study, Am J Clin Nutr, 92, 194, 10.3945/ajcn.2009.29054 · DOI
  21. AS Biong, 2006, Intake of milk fat, reflected in adipose tissue fatty acids and risk of myocardial infarction: a case-control study, Eur J Clin Nutr, 60, 236, 10.1038/sj.ejcn.1602307 · DOI
  22. Q Sun, 2007, Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease, Am J Clin Nutr, 86, 929, 10.1093/ajcn/86.4.929 · DOI · Paper page
  23. K Yamagishi, 2008, Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study, Am Heart J, 156, 965, 10.1016/j.ahj.2008.06.017 · DOI · Paper page
  24. K Yamagishi, 2013, Plasma fatty acid composition and incident ischemic stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study, Cerebrovasc Dis, 36, 38, 10.1159/000351205 · DOI
  25. VS Malik, 2012, Plasma and erythrocyte biomarkers of dairy fat intake and risk of coronary heart disease in men, Circulation, 125
  26. C Matsumoto, 2013, Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians’ Health Study, Clin Nutr, 32, 819, 10.1016/j.clnu.2013.02.006 · DOI
  27. OA Tokede, 2013, Plasma phospholipid trans fatty acids and risk of heart failure, Am J Clin Nutr, 97, 698, 10.3945/ajcn.112.050120 · DOI
  28. S Yaemsiri, 2013, Serum fatty acids and incidence of ischemic stroke among postmenopausal women, Stroke, 44, 2710, 10.1161/STROKEAHA.111.000834 · DOI · Paper page
  29. NR Matthan, 2014, Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women’s Health Initiative observational study, J Am Heart Assoc, 3, e000764, 10.1161/JAHA.113.000764 · DOI
  30. ME Kleber, 2016, Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study, Eur Heart J, 37, 1072, 10.1093/eurheartj/ehv446 · DOI · Paper page
  31. D Iggman, 2016, Association of Adipose Tissue Fatty Acids With Cardiovascular and All-Cause Mortality in Elderly Men, JAMA Cardiol, 1, 745, 10.1001/jamacardio.2016.2259 · DOI · Paper page
  32. ASD Laursen, 2019, Adipose tissue fatty acids present in dairy fat and risk of stroke: the Danish Diet, Cancer and Health cohort, Eur J Nutr, 58, 529, 10.1007/s00394-018-1608-2 · DOI
  33. H Borgeraas, 2016, Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study, Lipids Health Dis, 15, 38, 10.1186/s12944-016-0204-9 · DOI
  34. S Venn-Watson, 2020, Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?, Sci Rep, 10, 8161, 10.1038/s41598-020-64960-y · DOI · Paper page
  35. A Shioi, 2020, The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification, Nutrients, 12, 10.3390/nu12020583 · DOI
  36. F Gholami, 2017, The effect of dairy consumption on the prevention of cardiovascular diseases: A meta-analysis of prospective studies, J Cardiovasc Thorac Res, 9, 1, 10.15171/jcvtr.2017.01 · DOI · Paper page
  37. LQ Qin, 2015, Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies, Asia Pac J Clin Nutr, 24, 90
  38. AGD Astrup, 2014, Confusing message about dairy from Sweden (Rapid response to Milk intake and risk of mortality and fractures in women and men: cohort studies), BMJ, 349, g6015, 10.1136/bmj.g6015 · DOI · Paper page
  39. G Tognon, 2018, Dairy product intake and mortality in a cohort of 70-year-old Swedes: a contribution to the Nordic diet discussion, Eur J Nutr, 57, 2869, 10.1007/s00394-017-1556-2 · DOI
  40. K Michaëlsson, 2014, Milk intake and risk of mortality and fractures in women and men: cohort studies, BMJ, 349, g6015, 10.1136/bmj.g6015 · DOI · Paper page
  41. G Tognon, 2017, Nonfermented milk and other dairy products: associations with all-cause mortality, Am J Clin Nutr, 105, 1502, 10.3945/ajcn.116.140798 · DOI
  42. SC Larsson, 2015, Milk Consumption and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis, Nutrients, 7, 7749, 10.3390/nu7095363 · DOI
  43. MY Yakoob, 2016, Circulating Biomarkers of Dairy Fat and Risk of Incident Diabetes Mellitus Among Men and Women in the United States in Two Large Prospective Cohorts, Circulation, 133, 1645, 10.1161/CIRCULATIONAHA.115.018410 · DOI
  44. F Imamura, 2018, Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies, PLoS Med, 15, e1002670, 10.1371/journal.pmed.1002670 · DOI · Paper page
  45. A Astrup, 2019, Effects of Full-Fat and Fermented Dairy Products on Cardiometabolic Disease: Food Is More Than the Sum of Its Parts, Adv Nutr, 10, 924S, 10.1093/advances/nmz069 · DOI
  46. J Hjerpsted, 2011, Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content, Am J Clin Nutr, 94, 1479, 10.3945/ajcn.111.022426 · DOI · Paper page
  47. MU Jakobsen, 2021, Intake of dairy products and associations with major atherosclerotic cardiovascular diseases: a systematic review and meta-analysis of cohort studies, Sci Rep, 11, 1303, 10.1038/s41598-020-79708-x · DOI
  48. J Fontecha, 2019, Milk and Dairy Product Consumption and Cardiovascular Diseases: An Overview of Systematic Reviews and Meta-Analyses, Adv Nutr, 10, S164, 10.1093/advances/nmy099 · DOI · Paper page
  49. L Pimpin, 2016, Is Butter Back? A Systematic Review and Meta-Analysis of Butter Consumption and Risk of Cardiovascular Disease, Diabetes, and Total Mortality, PLoS ONE, 11, e0158118, 10.1371/journal.pone.0158118 · DOI · Paper page
  50. Y Zhang, 2021, Cooking oil/fat consumption and deaths from cardiometabolic diseases and other causes: prospective analysis of 521,120 individuals, BMC Med, 19, 92, 10.1186/s12916-021-01961-2 · DOI
  51. M Marklund, 2019, Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality, Circulation, 139, 2422, 10.1161/CIRCULATIONAHA.118.038908 · DOI · Paper page

Cited by

See all 94

Metadata

Authors
Trieu, K., Bhat, S., Dai, Z., Leander, K., Gigante, B., Qian, F., Korat, A. V. A., Sun, Q., Pan, X.-F., Laguzzi, F., Cederholm, T., de Faire, U., Hellénius, M.-L., Wu, J. H. Y., Risérus, U., & Marklund, M.
Venue
PLOS Medicine
Published
2021-09-21
Volume
18
Issue
9
Pages
e1003763
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W3199246387
Cited by
94
References
8
FWCI
3.71
Type
journal article
Language
en
Open access
gold
Funders
  • Stockholms Läns Landsting
  • Hjärt-Lungfonden
  • Vetenskapsrådet
  • National Health and Medical Research Council (APP1117300, APP1161597, APP1139997)
  • National Heart Foundation of Australia (102140)
  • University of New South Wales
  • National Institutes of Health (T32 CA009001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pmed.1003763
The paper
Trieu, K., Bhat, S., Dai, Z., Leander, K., Gigante, B., Qian, F., Korat, A. V. A., Sun, Q., Pan, X.-F., Laguzzi, F., Cederholm, T., de Faire, U., Hellénius, M.-L., Wu, J. H. Y., Risérus, U., & Marklund, M. (2021). Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003763

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.